
Overview
Bruce L. Jacobs, MD, is an associate professor of urology at the University of Pittsburgh School of Medicine. He received a medical degree from the Vanderbilt University School of Medicine in Nashville, Tenn., and earned a master’s degree in public health from the University of Michigan School of Public Health. Dr. Jacobs completed residencies in general surgery and urology at the University of Pittsburgh, and fellowships in health services research, laparoscopy/endourology, and urologic oncology at the University of Michigan.
Dr. Jacobs is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Prostatectomy, and Ureteroscopy.
His clinical research consists of co-authoring 191 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Muscle Invasive Bladder Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5200 Centre Avenue, Suite 209, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
UPMC Department Of Urology
Benjamin J. Davies, MD, is a professor of urology at the University of Pittsburgh. He specializes in robotic prostatectomy, robotic cystectomy, and kidney and testicular cancer. Dr. Davies is board-certified in urology. He completed an undergraduate degree at Columbia University in New York and a medical degree at Mount Sinai Medical School in New York. Dr. Davies completed a residency at UPMC, and a fellowship of urologic oncology at University of California, San Francisco. Dr. Davies is a member of professional organizations, such as the American Urologic Association, American Medical Association and the Pittsburgh Urologic Society. He also maintains research interests in prostate cancer epidemiology and surgical outcomes. Dr. Davies is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Cervical Myelopathy, Bladder Cancer, Prostate Cancer, Nephrectomy, and Prostatectomy.
West Virginia University Hospitals
Thomas Hogan is an Oncologist in Morgantown, West Virginia. Dr. Hogan is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and Renal Cell Carcinoma (RCC).
UPMC Department Of Urology
Tatum V. Tarin, MD, is an Associate Professor of Urology at the University of Pittsburgh School of Medicine. He earned his medical degree from the University of Pittsburgh, and completed residencies in surgery and urology at Stanford University Medical Center. He also completed a fellowship in urological oncology at Memorial Sloan-Kettering Cancer Center in New York, N.Y., where he was a clinical instructor for two years prior to joining UPMC. Dr. Tarin is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Lymphadenectomy, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bladder CancerDr. Jacobs isDistinguished. Learn about Bladder Cancer.
- Muscle Invasive Bladder CancerDr. Jacobs isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Jacobs isDistinguished. Learn about Prostate Cancer.
- ProstatectomyDr. Jacobs isDistinguished. Learn about Prostatectomy.
- Advanced
- Familial Prostate CancerDr. Jacobs isAdvanced. Learn about Familial Prostate Cancer.
- NephrectomyDr. Jacobs isAdvanced. Learn about Nephrectomy.
- Non-Muscle Invasive Bladder Cancer
- UreteroscopyDr. Jacobs isAdvanced. Learn about Ureteroscopy.
- Urothelial CancerDr. Jacobs isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Jacobs isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerDr. Jacobs isExperienced. Learn about Anal Cancer.
- BoilsDr. Jacobs isExperienced. Learn about Boils.
- CarbuncleDr. Jacobs isExperienced. Learn about Carbuncle.
- Chromophobe Renal Cell CarcinomaDr. Jacobs isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Jacobs isExperienced. Learn about Clear Cell Sarcoma.


